Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated with JAK Inhibitor Tofacitinib versus TNF Inhibitors: a Systematic Review, Meta Analysis, and Meta Regression. JIMKI [Internet]. 2025 Dec. 10 [cited 2026 Jul. 25];:4. Available from: https://jimki.bapin.or.id/main/article/view/949